For research use only
| Cat No. | ABC-SC0124T |
| Product Type | Human iPSCs |
| Cell Type | Induced Pluripotent Stem Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Disease | Normal |
| Storage | Liquid Nitrogen |
CHD8+/+ induced pluripotent stem cells (iPSC) were derived from skin fibroblasts
HighQC™ CHD8+/+ Induced Pluripotent Stem Cells (iPSCs) are human iPSCs derived from skin fibroblasts obtained from a typically developing male donor with a normal karyotype. CHD8+/+ iPSCs exhibit typical human pluripotent stem cell morphology, forming compact, tightly packed colonies with well-defined borders, large nuclei, minimal cytoplasm, and clonal growth under adherent culture conditions. The cells were generated using integration-free reprogramming methods, such as Sendai virus–mediated delivery of defined transcription factors, to induce pluripotency. CHD8+/+ iPSCs exhibit positive expression of SSEA-4. They retain the capacity to differentiate into derivatives of all three germ layers—ectoderm, mesoderm, and endoderm—under directed differentiation conditions. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | HighQC™ CHD8+/+ Induced Pluripotent Stem Cell, CHD8-WT-iPSC, CHD8 Wild-Type iPSC Line |
| Species | Human |
| Cat.No | ABC-SC0124T |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Induced Pluripotent Stem Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Disease | Normal |
| Biosafety Level | 2 |
| Storage | Liquid Nitrogen |
| Product Type | Human iPSCs |
HighQC™ CHD8+/+ Induced Pluripotent Stem Cells (iPSCs), also known as CHD8 wild-type isogenic control iPSCs, serve as an isogenic control for CHD8+/− iPSCs, providing a robust in vitro platform to study human brain development, neurodevelopmental mechanisms, and gene regulation. These cells are widely used to investigate CHD8’s role in chromatin dynamics, transcriptional regulation, and cell cycle control via interactions with p53, as well as to examine molecular pathways underlying neurodevelopmental disorders such as autism spectrum disorder.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).